Investigational New Drug application planned for submission to the U.S. FDA in the fourth quarter of 2026, advancing the Company’s regulatory path toward NDA filing for gout program XRx-026 CALGARY, Alberta, Sept. 18, 2026 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX), a late-stage clinical pharmaceutical company focused on developing innovative therapies […]
A new, affordable sickle cell treatment made in Senegal is raising hopes for patients by reducing costs and addressing shortages of imported medicines.
French biotech newcomer AbTx just pulled in €1.7 million—about $2 million—in a fresh seed round. Established in 2024, the startup is laser-focused on crafting precision therapies for solid tumors that…
Medical Director of Ultimate Clinic, Dr Daniel Fordjour, has advised that men can reduce their risk of developing prostate problems by adopting healthier lifestyles and undergoing regular medical…
CHLA named among the top 10 pediatric hospitals in the United States by U.S. News & World Report and ranked No. 5 in Pediatrics worldwide by Newsweek LOS ANGELES — Children’s Hospital Los Angeles…
Lucknow, September 18: Positive changes are becoming visible in the health and nutrition profile of Uttar Pradesh children due to the efforts of the Yogi government.
